Dr. Laughon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 984-974-1000Fax+1 919-966-7772
Education & Training
- University of North Carolina HospitalsFellowship, Neonatal-Perinatal Medicine, 2001 - 2004
- University of North Carolina at Chapel HillMPH, Epidemiology, 2004
- University of North Carolina HospitalsResidency, Pediatrics, 1998 - 2001
- University of Virginia School of MedicineClass of 1998
- Davidson CollegeB.S., Magna Cum Laude, 1994
Certifications & Licensure
- NC State Medical License 1999 - 2025
- American Board of Pediatrics Neonatal-Perinatal Medicine
Awards, Honors, & Recognition
- K30 Scholar-Clinical Research Curriculum NIH, 2003
- Phi Beta Kappa 1993
- Samuel H. Bell Honor Scholar Davidson College, 1990
Clinical Trials
- SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants. Start of enrollment: 2005 Feb 01
- Pharmacokinetics of Off Label Pediatric Medications Start of enrollment: 2010 Jul 01
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsDaily mortality of infants born at less than 30 weeks' gestationChristoph P. Hornik, Ashley L. Sherwood, C. Michael Cotten, Matthew M. Laughon, Reese H. Clark
Early Human Development. 2016-05-01 - 64 citationsMedication Use in the Neonatal Intensive Care Unit and Changes from 2010 to 2018Ashley Stark, P. Brian Smith, Christoph P. Hornik, Kanecia O. Zimmerman, Chi D. Hornik
The Journal of Pediatrics. 2021-09-02 - 4 citationsExposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus disease.Jessica E Ericson, Daniel K Benjamin Jr, Felix Boakye-Agyeman, Stephen J Balevic, C Michael Cotten
Early Human Development. 2022-07-01
Journal Articles
- Agreement of an Echocardiogram-Based Diagnosis of Pulmonary Hypertension in Infants at Risk for Bronchopulmonary Dysplasia Among Masked ReviewersRachel D Torok, Matthew M Laughon, Andrew W McCrary, Christoph P Hornik, Jennifer S Li, Nature
- Characterization of the Population Pharmacokinetics of Ampicillin in Neonates Using an Opportunistic Study DesignTremoulet A, Le J, Poindexter B, Sullivan JE, Laughon M, Delmore P, Salgado A, Ian-U Chong S, Melloni C, Gao J, Benjamin DK Jr, Capparelli EV, Cohen-Wolkowiez M; on be..., Antimicrob Agents Chemother, 6/1/2014
- Trends in Caffeine Use and Association between Clinical Outcomes and Timing of Therapy in Very Low Birth Weight InfantsDobson NR, Patel RM, Smith PB, Kuehn DR, Clark J, Vyas-Read S, Herring A, Laughon MM, Carlton D, Hunt CE, J Pediatr, 5/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Sedatives and Analgesics Given To Dying Infants in Neonatal Intensive Care Units.Zimmerman KO, Hornik CP, Watt KM, Clark RH, Laughon MM, Smith PB, PAS, 1/1/2014
- Analysis of the BPCA Priority List: Are Drug Priorities Reflective of Clinical Need in Hospitalized Infants?Gostelow M, Tripathi N, Benjamin Jr DB, Hornik CP, Cohen-Wolkowiez M, Clark R, Laughon MM, Smith PB, PAS, 1/1/2014
- Join now to see all
Press Mentions
- Prolonged Duration of Early Antibiotic Therapy in Extremely Premature InfantsJune 1st, 2019
- Neurodevelopmental Outcomes Among Extremely Premature Infants with Linear Growth RestrictionOctober 23rd, 2018
- Why Are NICU Drugs Largely Untested?September 13th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: